Published in Nature on September 25, 1997
Obesity and insulin resistance. J Clin Invest (2000) 10.47
Adipocytes as regulators of energy balance and glucose homeostasis. Nature (2006) 9.52
Life without white fat: a transgenic mouse. Genes Dev (1998) 5.08
Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev (2000) 4.57
The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest (2003) 4.11
Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest (2000) 3.41
AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest (2006) 3.39
Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest (1999) 3.36
Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest (2005) 3.10
Central melanocortin receptors regulate insulin action. J Clin Invest (2001) 2.83
Inflammatory mechanisms in the regulation of insulin resistance. Mol Med (2008) 2.71
Leptin secretion and leptin receptor in the human stomach. Gut (2000) 2.46
Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol (2008) 2.42
Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc Natl Acad Sci U S A (2004) 2.36
Sixteen years and counting: an update on leptin in energy balance. J Clin Invest (2011) 2.21
Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J Clin Invest (2012) 2.12
Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest (2005) 2.01
Leptin and the central nervous system control of glucose metabolism. Physiol Rev (2011) 1.94
Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice. J Lipid Res (2008) 1.91
Potential of surgery for curing type 2 diabetes mellitus. Ann Surg (2002) 1.88
Leptin-dependent control of glucose balance and locomotor activity by POMC neurons. Cell Metab (2009) 1.79
Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J Clin Invest (2004) 1.71
Hyperleptinemia is required for the development of leptin resistance. PLoS One (2010) 1.55
Targeting the AMPK pathway for the treatment of Type 2 diabetes. Front Biosci (Landmark Ed) (2009) 1.51
Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer. Cancer Res (2013) 1.50
Adipocytokines in obesity and metabolic disease. J Endocrinol (2014) 1.49
Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells. J Biol Chem (2008) 1.41
Distinct effects of leptin and a melanocortin receptor agonist injected into medial hypothalamic nuclei on glucose uptake in peripheral tissues. Diabetes (2009) 1.33
Normal hepatic glucose production in the absence of GLUT2 reveals an alternative pathway for glucose release from hepatocytes. Proc Natl Acad Sci U S A (1998) 1.30
Hepatic glucose sensing is required to preserve β cell glucose competence. J Clin Invest (2013) 1.27
Cardiovascular effects of leptin. Nat Rev Cardiol (2009) 1.26
Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice. Mol Cell Biol (2009) 1.19
Leptin and Inflammation. Curr Immunol Rev (2008) 1.19
Selective interaction between leptin and insulin signaling pathways in a hepatic cell line. Proc Natl Acad Sci U S A (2000) 1.14
FOXO1 in the ventromedial hypothalamus regulates energy balance. J Clin Invest (2012) 1.13
Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling. Diabetes (2011) 1.10
Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery. Am J Med (2009) 1.08
Hyperleptinemia without obesity in male mice lacking androgen receptor in adipose tissue. Endocrinology (2008) 1.05
Central leptin receptor action and resistance in obesity. J Investig Med (2009) 1.03
Extracellular signal-regulated kinase in the ventromedial hypothalamus mediates leptin-induced glucose uptake in red-type skeletal muscle. Diabetes (2013) 1.02
Tyrosine-dependent and -independent actions of leptin receptor in control of energy balance and glucose homeostasis. Proc Natl Acad Sci U S A (2008) 1.02
GLUT4, AMP kinase, but not the insulin receptor, are required for hepatoportal glucose sensor-stimulated muscle glucose utilization. J Clin Invest (2003) 1.01
The role of leptin in the control of insulin-glucose axis. Front Neurosci (2013) 1.00
AMP-activated protein kinase and metabolic control. Handb Exp Pharmacol (2011) 0.99
Structure, production and signaling of leptin. Metabolism (2014) 0.98
Natural selection and adaptive evolution of leptin in the ochotona family driven by the cold environmental stress. PLoS One (2008) 0.96
Cross down-regulation of leptin and insulin receptor expression and signalling in a human neuronal cell line. Biochem J (2005) 0.96
Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation. Peptides (2009) 0.96
Revisiting the Ventral Medial Nucleus of the Hypothalamus: The Roles of SF-1 Neurons in Energy Homeostasis. Front Neurosci (2013) 0.96
Intracerebroventricular leptin regulates hepatic cholesterol metabolism. Biochem J (2004) 0.96
Direct and indirect effects of leptin on adipocyte metabolism. Biochim Biophys Acta (2013) 0.95
Leptin-mediated changes in hepatic mitochondrial metabolism, structure, and protein levels. Proc Natl Acad Sci U S A (2009) 0.95
The brain subfornical organ mediates leptin-induced increases in renal sympathetic activity but not its metabolic effects. Hypertension (2013) 0.95
Dietary and genetic evidence for enhancing glucose metabolism and reducing obesity by inhibiting klotho functions. FASEB J (2011) 0.95
Regulatory role of leptin in glucose and lipid metabolism in skeletal muscle. Indian J Endocrinol Metab (2012) 0.92
Role of leptin in the regulation of growth and carbohydrate metabolism in the ovine fetus during late gestation. J Physiol (2008) 0.91
Innervation of skeletal muscle by leptin receptor-containing neurons. Brain Res (2010) 0.90
The role of leptin in glucose homeostasis. J Diabetes Investig (2012) 0.90
Adipokines and insulin action: A sensitive issue. Adipocyte (2014) 0.88
Leptin signaling and Alzheimer's disease. Am J Neurodegener Dis (2012) 0.88
Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action. J Clin Invest (1998) 0.87
Mathematical models of energy homeostasis. J R Soc Interface (2008) 0.85
Taeyeumjoweetang Affects Body Weight and Obesity-related Genes in Mice. Evid Based Complement Alternat Med (2009) 0.84
Leptin reduces the expression and increases the phosphorylation of the negative regulators of GLUT4 traffic TBC1D1 and TBC1D4 in muscle of ob/ob mice. PLoS One (2012) 0.83
Leptin recruits Creb-regulated transcriptional coactivator 1 to improve hyperglycemia in insulin-deficient diabetes. Mol Metab (2014) 0.83
Impaired insulin secretion and enhanced insulin sensitivity in cholecystokinin-deficient mice. Diabetes (2011) 0.83
Dietary fat impacts fetal growth and metabolism: uptake of chylomicron remnant core lipids by the placenta. Am J Physiol Endocrinol Metab (2011) 0.83
Smoking Habits and Neuropeptides: Adiponectin, Brain-derived Neurotrophic Factor, and Leptin Levels. Toxicol Res (2014) 0.82
Multigenerational impact of maternal overnutrition/obesity in the sheep on the neonatal leptin surge in granddaughters. Int J Obes (Lond) (2014) 0.82
Euglycemia Restoration by Central Leptin in Type 1 Diabetes Requires STAT3 Signaling but Not Fast-Acting Neurotransmitter Release. Diabetes (2016) 0.82
Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults. Cardiovasc Diabetol (2007) 0.82
Targeted therapies of the LKB1/AMPK pathway for the treatment of insulin resistance. Future Med Chem (2010) 0.82
Cardiomyocyte-specific deletion of leptin receptors causes lethal heart failure in Cre-recombinase-mediated cardiotoxicity. Am J Physiol Regul Integr Comp Physiol (2012) 0.81
Minireview: CNS Mechanisms of Leptin Action. Mol Endocrinol (2015) 0.81
Adipocytokine profile and insulin resistance in childhood obesity. Maedica (Buchar) (2012) 0.81
Leptin augments the acute suppressive effects of insulin on hepatic very low-density lipoprotein production in rats. Endocrinology (2009) 0.81
Apolipoprotein E reduces food intake via PI3K/Akt signaling pathway in the hypothalamus. Physiol Behav (2011) 0.81
Leptin, diabetes, and the brain. Indian J Endocrinol Metab (2012) 0.80
Exercise and obesity in fibromyalgia: beneficial roles of IGF-1 and resistin? Arthritis Res Ther (2013) 0.80
Leptin in the field of hepatic fibrosis: a pivotal or an incidental player? Dig Dis Sci (2006) 0.80
Brain-mediated antidiabetic, anorexic, and cardiovascular actions of leptin require melanocortin-4 receptor signaling. J Neurophysiol (2015) 0.79
Epistasis between hyperglycemic QTLs revealed in a double congenic of the OLETF rat. Mamm Genome (2007) 0.79
Lipid transport in cholecystokinin knockout mice. Physiol Behav (2015) 0.78
Living without insulin: the role of leptin signaling in the hypothalamus. Front Neurosci (2015) 0.78
Smoking is associated with reduced leptin and neuropeptide Y levels and higher pain experience in patients with fibromyalgia. Mediators Inflamm (2014) 0.78
Risk of postprandial insulin resistance: the liver/vagus rapport. Rev Endocr Metab Disord (2014) 0.78
Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies. Transl Psychiatry (2013) 0.78
Leptin Dysfunction and Alzheimer's Disease: Evidence from Cellular, Animal, and Human Studies. Cell Mol Neurobiol (2016) 0.77
Leptin Is Required for Glucose Homeostasis after Roux-en-Y Gastric Bypass in Mice. PLoS One (2015) 0.77
Is there an estrogenic component in the metabolic syndrome? Genes Nutr (2006) 0.77
Metabolic stressors and signals differentially affect energy allocation between reproduction and immune function. Gen Comp Endocrinol (2014) 0.77
Can salivary phosphate levels be an early biomarker to monitor the evolvement of obesity? Contrib Nephrol (2013) 0.77
Association of common variants in JAK2 gene with reduced risk of metabolic syndrome and related disorders. BMC Med Genet (2011) 0.77
Serum Leptin Levels and the Risk of Stroke: The Framingham Study. Stroke (2015) 0.76
Lean heart: Role of leptin in cardiac hypertrophy and metabolism. World J Cardiol (2015) 0.76
Leptin ameliorates ischemic necrosis of the femoral head in rats with obesity induced by a high-fat diet. Sci Rep (2015) 0.76
Leptin acts in the brain to influence hypoglycemic counterregulation: disparate effects of acute and recurrent hypoglycemia on glucagon release. Am J Physiol Endocrinol Metab (2015) 0.75
Leptin at gender-specific concentrations does not affect glucose transport, expression of glucose transporters and leptin receptors in human lymphocytes. Endocrine (2014) 0.75
Effects of the Combined Extracts of Grape Pomace and Omija Fruit on Hyperglycemia and Adiposity in Type 2 Diabetic Mice. Prev Nutr Food Sci (2015) 0.75
An acute method to test leptin responsiveness in rats. Am J Physiol Regul Integr Comp Physiol (2014) 0.75
Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 38.85
Leptin and the regulation of body weight in mammals. Nature (1998) 14.84
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science (1992) 14.70
Weight-reducing effects of the plasma protein encoded by the obese gene. Science (1995) 13.05
Abnormal splicing of the leptin receptor in diabetic mice. Nature (1996) 7.71
Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell (2000) 5.73
Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet (1996) 4.84
Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev (2000) 4.57
Genetic and crystallographic studies of the 3',5'-exonucleolytic site of DNA polymerase I. Science (1988) 4.50
Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest (2001) 3.82
Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A (1997) 3.81
Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature (2001) 3.65
Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol Cell Biol (2000) 3.60
Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A (2003) 3.53
Diagnostic criteria for schwannomatosis. Neurology (2005) 3.41
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet (2002) 3.35
Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc Natl Acad Sci U S A (1995) 3.33
Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature (1995) 3.04
Cocrystal structure of an editing complex of Klenow fragment with DNA. Proc Natl Acad Sci U S A (1988) 3.02
Virus-assisted mapping of neural inputs to a feeding center in the hypothalamus. Science (2001) 2.98
Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol Chem (2001) 2.91
Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet (2001) 2.78
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1994) 2.71
Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation (2001) 2.64
NF1 gene and neurofibromatosis 1. Am J Epidemiol (2000) 2.58
Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci U S A (1997) 2.57
Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet (2000) 2.49
Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer. Proc Natl Acad Sci U S A (1994) 2.47
GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat Med (1997) 2.37
Crystal structures of the Klenow fragment of DNA polymerase I complexed with deoxynucleoside triphosphate and pyrophosphate. Biochemistry (1993) 2.19
C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia (2007) 2.19
Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics (2003) 2.11
Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia (2011) 2.00
A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1alpha. J Med Genet (2007) 1.94
Differential regulation of two glucose transporters in adipose cells from diabetic and insulin-treated diabetic rats. J Clin Invest (1989) 1.89
Drug safety in pregnant women and their babies: ignorance not bliss. Clin Pharmacol Ther (2007) 1.87
Linkage of functional and structural heterogeneity in proteins: dynamic hole burning in carboxymyoglobin. Science (1987) 1.87
Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proc Natl Acad Sci U S A (1997) 1.85
Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet (2003) 1.85
Increasing the specificity of diagnostic criteria for schwannomatosis. Neurology (2006) 1.85
An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. Proc Natl Acad Sci U S A (1993) 1.83
Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children. Neurology (2000) 1.83
The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes. Diabetologia (2009) 1.82
On the use of population attributable fraction to determine sample size for case-control studies of gene-environment interaction. Epidemiology (2003) 1.82
Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics (2000) 1.79
Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol (2002) 1.76
Assessment of algorithms for high throughput detection of genomic copy number variation in oligonucleotide microarray data. BMC Bioinformatics (2007) 1.75
Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia. Diabetologia (2006) 1.74
Cellular promoters incorporated into the adenovirus genome: cell specificity of albumin and immunoglobulin expression. Mol Cell Biol (1986) 1.73
Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. Am J Med Genet (2000) 1.70
Immunoelectron microscopic demonstration of insulin-stimulated translocation of glucose transporters to the plasma membrane of isolated rat adipocytes and masking of the carboxyl-terminal epitope of intracellular GLUT4. Proc Natl Acad Sci U S A (1991) 1.69
A reevaluation of risk of in utero exposure to lithium. JAMA (1994) 1.68
Submicroscopic deletions and duplications in individuals with intellectual disability detected by array-CGH. Am J Med Genet A (2005) 1.68
Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet (2011) 1.68
Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem Soc Trans (2003) 1.67
Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of Micronesia. Hum Hered (2001) 1.67
Molecular physiology of glucose transporters. Diabetes Care (1990) 1.67
Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurology (2005) 1.65
Transcriptional and post-transcriptional control of specific messenger RNAs in adult and embryonic liver. J Mol Biol (1984) 1.63
Hypoglycemia leads to age-related loss of vision. Proc Natl Acad Sci U S A (2006) 1.59
Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation (2006) 1.58
Transgenic reexpression of GLUT1 or GLUT2 in pancreatic beta cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion. J Biol Chem (2000) 1.57
Structural and functional analysis of the MAL1 locus of Saccharomyces cerevisiae. Mol Cell Biol (1986) 1.56
Orphan receptor HNF-4 and bZip protein C/EBP alpha bind to overlapping regions of the apolipoprotein B gene promoter and synergistically activate transcription. J Biol Chem (1993) 1.54
Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology (2002) 1.53
Comparison of the 15q deletions in Prader-Willi and Angelman syndromes: specific regions, extent of deletions, parental origin, and clinical consequences. Am J Med Genet (1990) 1.53
Ordered water molecules as key allosteric mediators in a cooperative dimeric hemoglobin. Proc Natl Acad Sci U S A (1996) 1.51
Update on new developments in the study of human teratogens. Teratology (2002) 1.49
Insulin and nonhydrolyzable GTP analogs induce translocation of GLUT 4 to the plasma membrane in alpha-toxin-permeabilized rat adipose cells. J Biol Chem (1991) 1.48
Excited state lifetimes in cytochromes measured from Raman scattering data: evidence for iron-porphyrin interactions. Proc Natl Acad Sci U S A (1977) 1.48
Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathol Biol (Paris) (2008) 1.47
Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001-2002. Am J Clin Nutr (2007) 1.46
Transient Raman study of CO-haemoprotein photolysis: origin of the quantum yield. Nature (1980) 1.43
Workshop report: evaluation of genetic and epigenetic risks associated with assisted reproductive technologies and infertility. Fertil Steril (2007) 1.42
Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. Am J Med Genet (1999) 1.40
Normal kinetics of intestinal glucose absorption in the absence of GLUT2: evidence for a transport pathway requiring glucose phosphorylation and transfer into the endoplasmic reticulum. Proc Natl Acad Sci U S A (2001) 1.39
Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene. J Clin Invest (1997) 1.37
Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet (2002) 1.37
The iron-proximal histidine linkage and protein control of oxygen binding in hemoglobin. A transient Raman study. J Biol Chem (1983) 1.35
del(20p) with manifestations of arteriohepatic dysplasia. Am J Med Genet (1986) 1.35
Saethre-Chotzen syndrome: a broad and variable pattern of skeletal malformations. J Pediatr (1977) 1.35
Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes (1996) 1.34
Site-specific PEGylation of hemoglobin at Cys-93(beta): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain. Bioconjug Chem (2003) 1.34
Expression of ob gene in adipose cells. Regulation by insulin. J Biol Chem (1996) 1.31
Clinical, genetic, and epidemiological factors in neural tube defects. Am J Hum Genet (1988) 1.31
Normal hepatic glucose production in the absence of GLUT2 reveals an alternative pathway for glucose release from hepatocytes. Proc Natl Acad Sci U S A (1998) 1.30
Rat obesity gene fatty (fa) maps to chromosome 5: evidence for homology with the mouse gene diabetes (db). Proc Natl Acad Sci U S A (1991) 1.30
Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats. J Clin Invest (1991) 1.30
Structure, dynamics, and reactivity in hemoglobin. Science (1985) 1.29
Gene expression during liver regeneration. J Mol Biol (1984) 1.27
Diverse effects of Glut 4 ablation on glucose uptake and glycogen synthesis in red and white skeletal muscle. J Clin Invest (1996) 1.26
Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Neurology (2002) 1.25
n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Diabetologia (2009) 1.25
Protein-heme interaction in hemoglobin: evidence from Raman difference spectroscopy. Proc Natl Acad Sci U S A (1979) 1.24
Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am J Clin Nutr (2008) 1.23
Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction. Proc Natl Acad Sci U S A (1999) 1.23